Global Newborn Screening Market Size & Outlook, 2025-2033
Global newborn screening market, 2021-2033 (US$M)
Related Markets
Global newborn screening market highlights
- The global newborn screening market generated a revenue of USD 900.6 million in 2024 and is expected to reach USD 1,797.4 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 8.1% by 2033.
- In terms of segment, tandem mass spectrometry accounted for a revenue of USD 240.0 million in 2024.
- Tandem Mass Spectrometry is the most lucrative technology segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 900.6 million |
| Market revenue in 2033 | USD 1,797.4 million |
| Growth rate | 8.1% (CAGR from 2025 to 2033) |
| Largest segment | Tandem mass spectrometry |
| Fastest growing segment | Tandem Mass Spectrometry |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
Other key industry trends
- In terms of revenue, the North America accounted for 16.6% of the global newborn screening market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, India is the fastest growing regional market and is projected to reach USD 111.7 million by 2033.
Tandem mass spectrometry was the largest segment with a revenue share of 26.65% in 2024. Horizon Databook has segmented the Global newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2021 to 2033.
Extensively increasing prevalence of congenital diseases in newborns is expected to have a positive impact on the newborn screening market growth. According to a data published by WHO in February 2023, an estimated 240,000 newborns within 28 days of birth die each year globally due to congenital diseases.
In addition, according to information from Indian Pediatrics, congenital hypothyroidism occurs in 2.1 out of every 1,000 infants in India, and the prevalence of inborn metabolic abnormalities ranges from 2 to 7.8%. Such substantial occurrence of congenital diseases amongst newborns is likely to increase the adoption for tests, which will eventually accelerate the market growth by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Newborn Screening Market Scope
Newborn Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Covidien | View profile | 10001+ | Dublin, Dublin, Ireland, Europe | http://www.covidien.com |
| Natus Medical | View profile | 1001-5000 | San Carlos, California, United States, North America | http://www.natus.com |
| Agilent Technologies | View profile | 10001+ | Santa Clara, California, United States, North America | http://www.agilent.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Masimo Corp | View profile | 3796 | 52 Discovery, Irvine, CA, United States, 92618 | https://www.masimo.com |
| Waters Corp | View profile | 7900 | 34 Maple Street, Milford, MA, United States, 01757 | https://www.waters.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
Global newborn screening market size, by regions, 2021-2033 (US$M)
Top 10 countries: Newborn screening market size, 2024 (US$M)
Global newborn screening market share, by technology, 2024 & 2033 (%, US$M)
Newborn screening market: Opportunity assessment by country
Global newborn screening market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
